{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T17:03:22Z","timestamp":1775322202003,"version":"3.50.1"},"reference-count":49,"publisher":"The Society for Free Radical Research Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2020]]},"DOI":"10.3164\/jcbn.19-104","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T22:04:06Z","timestamp":1586383446000},"page":"232-239","source":"Crossref","is-referenced-by-count":9,"title":["Ability of plasma-activated acetated Ringer\u2019s solution to induce A549 cell injury is enhanced by a pre-treatment with histone deacetylase inhibitors"],"prefix":"10.3164","volume":"67","author":[{"given":"Tetsuo","family":"Adachi","sequence":"first","affiliation":[{"name":"Laboratory of Clinical Pharmaceutics, Gifu Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmaceutics, Gifu Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Ishii","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmaceutics, Gifu Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Kamiya","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmaceutics, Gifu Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Hara","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmaceutics, Gifu Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Kalghatgi S, Kelly CM, Cerchar E, et al. Effects of non-thermal plasma on mammalian cells. PLoS One 2011; 6: e16270.","DOI":"10.1371\/journal.pone.0016270"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Panngom K, Baik KY, Nam MK, Han JH, Rhim H, Choi EH. Preferential killing of human lung cancer cell lines with mitochondrial dysfunction by nonthermal dielectric barrier discharge plasma. Cell Death Dis 2013; 4: e642.","DOI":"10.1038\/cddis.2013.168"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Vandamme M, Robert E, Lerondel S, et al. ROS implication in a new antitumor strategy based on non-thermal plasma. Int J Cancer 2012; 130: 2185\u20132194.","DOI":"10.1002\/ijc.26252"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Kaneko T, Sasaki S, Takashima K, Kanzaki M. Gas-liquid interfacial plasmas producing reactive species for cell membrane permeabilization. J Clin Biochem Nutr 2017; 60: 3\u201311.","DOI":"10.3164\/jcbn.16-73"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Keidar M, Walk R, Shashurin A, et al. Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy. Br J Cancer 2011; 105: 1295\u20131301.","DOI":"10.1038\/bjc.2011.386"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Utsumi F, Kajiyama H, Nakamura K, et al. Effect of indirect nonequilibrium atmospheric pressure plasma on anti-proliferative activity against chronic chemo-resistant ovarian cancer cells <i>in vitro<\/i> and <i>in vivo<\/i>. PLoS One 2013; 8: e81576.","DOI":"10.1371\/journal.pone.0081576"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Tanaka H, Mizuno M, Toyokuni S, et al. Cancer therapy using non-thermal atmospheric pressure plasma with ultra-high electron density. Phys Plasma 2015; 22: 122004.","DOI":"10.1063\/1.4933402"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Tanaka H, Mizuno M, Ishikawa K, et al. Plasma-activated medium selectively kills glioblastoma brain tumor cells by down-regulating a survival signaling molecule, AKT kinase. Plasma Med 2011; 1: 265\u2013277.","DOI":"10.1615\/PlasmaMed.2012006275"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Hoentsch M, von Woedtke T, Weltmann K-D, Nebe JB. Time-dependent effects of low-temperature atmospheric-pressure argon plasma on epithelial cell attachment, viability and tight junction formation <i>in vitro<\/i>. J Phys D Appl Phys 2012; 45: 025206.","DOI":"10.1088\/0022-3727\/45\/2\/025206"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Hattori M, Yamada S, Torii K, et al. Effectiveness of plasma treatment on pancreatic cancer cells. Int J Oncol 2015; 47: 1655\u20131662.","DOI":"10.3892\/ijo.2015.3149"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Utsumi F, Kajiyama H, Nakamura K, et al. Variable susceptibility of ovarian cancer cells to non-thermal plasma-activated medium. Oncol Rep 2016; 35: 3169\u20133177.","DOI":"10.3892\/or.2016.4726"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Wada N, Ikeda JI, Tanaka H, et al. Effect of plasma-activated medium on the decrease of tumorigenic population in lymphoma. Pathol Res Pract 2017; 213: 773\u2013777.","DOI":"10.1016\/j.prp.2017.04.003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Nakamura K, Peng Y, Utsumi F, et al. Novel intraperitoneal treatment with non-thermal plasma-activated medium inhibits metastatic potential of ovarian cancer cells. Sci Rep 2017; 7: 6085.","DOI":"10.1038\/s41598-017-05620-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Ikeda JI, Tanaka H, Ishikawa K, Sakakita H, Ikehara Y, Hori M. Plasma-activated medium (PAM) kills human cancer-initiating cells. Pathol Int 2018; 68: 23\u201330.","DOI":"10.1111\/pin.12617"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Chauvin J, Gibot L, Griseti E, et al. Elucidation of <i>in vitro<\/i> cellular steps induced by antitumor treatment with plasma-activated medium. Sci Rep 2019; 9: 4866.","DOI":"10.1038\/s41598-019-41408-6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Adachi T, Tanaka H, Nonomura S, Hara H, Kondo S, Hori M. Plasma-activated medium induced A549 cell injury by a spiral apoptotic cascade involving the mitochondrial-nuclear network. Free Radic Biol Med 2015; 79: 28\u201344.","DOI":"10.1016\/j.freeradbiomed.2014.11.014"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Hara H, Taniguchi M, Kobayashi M, Kamiya T, Adachi T. Plasma-activated medium-induced intracellular zinc liberation causes death of SH-SY5Y cells. Arch Biochem Biophys 2015; 584: 51\u201360.","DOI":"10.1016\/j.abb.2015.08.014"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Adachi T, Nonomura S, Horiba M, et al. Iron stimulates plasma-activated medium-induced A549 cell injury. Sci Rep 2016; 6: 20928.","DOI":"10.1038\/srep20928"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Hara H, Sueyoshi S, Taniguchi M, Kamiya T, Adachi T. Differences in intracellular mobile zinc levels affect susceptibility to plasma-activated medium-induced cytotoxicity. Free Radic Res 2017; 51: 306\u2013315.","DOI":"10.1080\/10715762.2017.1309527"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Boehm D, Curtin J, Cullen PJ, Bourke P. Hydrogen peroxide and beyond-the potential of high-voltage plasma-activated liquids against cancerous cells. Anticancer Agents Med Chem 2018; 18: 815\u2013823.","DOI":"10.2174\/1871520617666170801110517"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Tanaka H, Nakamura K, Mizuno M, et al. Non-thermal atmospheric pressure plasma activates lactate in Ringer&apos;s solution for anti-tumor effects. Sci Rep 2016; 6: 36282.","DOI":"10.1038\/srep36282"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Sato Y, Yamada S, Takeda S, et al. Effect of plasma-activated lactated Ringer\u2019s solution on pancreatic cancer cells <i>in vitro<\/i> and <i>in vivo<\/i>. Ann Surg Oncol 2018; 25: 299\u2013307.","DOI":"10.1245\/s10434-017-6239-y"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Lane AA, Chabner BA. Histone deacetylase inhibitors in cancer therapy. J Clin Oncol 2009; 27: 5459\u20135468.","DOI":"10.1200\/JCO.2009.22.1291"},{"key":"24","unstructured":"24 Kim MS, Blake M, Baek JH, Kohlhagen G, Pommier Y, Carrier F. Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Cancer Res 2003; 63: 7291\u20137300."},{"key":"25","unstructured":"25 Gong Y, Ni ZH, Zhang X, Chen XH, Zou ZM. Valproic acid enhances the anti-tumor effect of (\u2013)-gossypol to Burkitt lymphoma Namalwa cells. Biomed Environ Sci 2015; 28: 773\u2013777."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Sharma NL, Groselj B, Hamdy FC, Kiltie AE. The emerging role of histone deacetylase (HDAC) inhibitors in urological cancers. BJU Int 2013; 111: 537\u2013542.","DOI":"10.1111\/j.1464-410X.2012.11647.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Mrkvicova A, Chmelarova M, Peterova E, et al. The effect of sodium butyrate and cisplatin on expression of EMT markers. PLoS One 2019; 14: e0210889.","DOI":"10.1371\/journal.pone.0210889"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Chie EK, Shin JH, Kim JH, Kim HJ, Kim IA, Kim IH. <i>In vitro<\/i> and <i>in vivo<\/i> radiosensitizing effect of valproic acid on fractionated irradiation. Cancer Res Treat 2015; 47: 527\u2013533.","DOI":"10.4143\/crt.2014.026"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Chinnaiyan P, Cerna D, Burgan WE, et al. Postradiation sensitization of the histone deacetylase inhibitor valproic acid. Clin Cancer Res 2008; 14: 5410\u20135415.","DOI":"10.1158\/1078-0432.CCR-08-0643"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Groselj B, Sharma NL, Hamdy FC, Kerr M, Kiltie AE. Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair. Br J Cancer 2013; 108: 748\u2013754.","DOI":"10.1038\/bjc.2013.21"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Moertl S, Payer S, Kell R, Winkler K, Anastasov N, Atkinson MJ. Comparison of radiosensitization by HDAC inhibitors CUDC-101 and SAHA in pancreatic cancer cells. Int J Mol Sci 2019; 20. pii: E3259.","DOI":"10.3390\/ijms20133259"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Lindsay J, Esposti MD, Gilmore AP. Bcl-2 proteins and mitochondria-specificity in membrane targeting for death. Biochim Biophys Acta 2011; 1813: 532\u2013539.","DOI":"10.1016\/j.bbamcr.2010.10.017"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Thomson TM, Balcells C, Cascante M. Metabolic plasticity and epithelial-mesenchymal transition. J Clin Med 2019; 8. pii: E967.","DOI":"10.3390\/jcm8070967"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Culley KL, Hui W, Barter MJ, et al. Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation. Arthritis Rheum 2013; 65: 1822\u20131830.","DOI":"10.1002\/art.37965"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Shoji M, Ninomiya I, Makino I, et al. Valproic acid, a histone deacetylase inhibitor, enhances radiosensitivity in esophageal squamous cell carcinoma. Int J Oncol 2012; 40: 2140\u20132146.","DOI":"10.3892\/ijo.2012.1416"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Adimoolam S, Sirisawad M, Chen J, Thiemann P, Ford JM, Buggy JJ. HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination. Proc Natl Acad Sci U S A 2007; 104: 19482\u201319487.","DOI":"10.1073\/pnas.0707828104"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Levraut J, Iwase H, Shao ZH, Vanden Hoek TL, Schumacker PT. Cell death during ischemia: relationship to mitochondrial depolarization and ROS generation. Am J Physiol Heart Circ Physiol 2003; 284: H549\u2013H558.","DOI":"10.1152\/ajpheart.00708.2002"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Sun S, Han Y, Liu J, et al. Trichostatin A targets the mitochondrial respiratory chain, increasing mitochondrial reactive oxygen species production to trigger apoptosis in human breast cancer cells. PLoS One 2014; 9: e91610.","DOI":"10.1371\/journal.pone.0091610"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Saito K, Asai T, Fujiwara K, et al. Tumor-selective mitochondrial network collapse induced by atmospheric gas plasma-activated medium. Oncotarget 2016; 7: 19910\u201319927.","DOI":"10.18632\/oncotarget.7889"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Conway GE, Casey A, Milosavljevic V, et al. Non-thermal atmospheric plasma induces ROS-independent cell death in U373MG glioma cells and augments the cytotoxicity of temozolomide. Br J Cancer 2016; 114: 435\u2013443.","DOI":"10.1038\/bjc.2016.12"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Conway GE, He Z, Hutanu AL, et al. Cold Atmospheric Plasma induces accumulation of lysosomes and caspase-independent cell death in U373MG glioblastoma multiforme cells. Sci Rep 2019; 9: 12891.","DOI":"10.1038\/s41598-019-49013-3"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Tanaka H, Mizuno M, Katsumata Y, et al. Oxidative stress-dependent and -independent death of glioblastoma cells induced by non-thermal plasma-exposed solutions. Sci Rep 2019; 9: 13657.","DOI":"10.1038\/s41598-019-50136-w"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Utsumi F, Kajiyama H, Nakamura K, Tanaka H, Hori M, Kikkawa F. Selective cytotoxicity of indirect nonequilibrium atmospheric pressure plasma against ovarian clear-cell carcinoma. Springerplus 2014; 3: 398.","DOI":"10.1186\/2193-1801-3-398"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Guerrero-Preston R, Ogawa T, Uemura M, et al. Cold atmospheric plasma treatment selectively targets head and neck squamous cell carcinoma cells. Int J Mol Med 2014; 34: 941\u2013946.","DOI":"10.3892\/ijmm.2014.1849"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Kajiyama H, Utsumi F, Nakamura K, et al. Possible therapeutic option of aqueous plasma for refractory ovarian cancer. Clin Plasma Med 2016; 4: 14\u201318.","DOI":"10.1016\/j.cpme.2015.12.002"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Schilsky RL, Choi KE, Grayhack J, Grimmer D, Guarnieri C, Fullem L. Phase I clinical and pharmacologic study of intraperitoneal cisplatin and fluorouracil in patients with advanced intraabdominal cancer. J Clin Oncol 1990; 8: 2054\u20132061.","DOI":"10.1200\/JCO.1990.8.12.2054"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 McArdle CS, Kerr DJ, O&apos;Gorman P, et al. Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinoma. Br J Cancer 1994; 70: 762\u2013766.","DOI":"10.1038\/bjc.1994.392"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Kim JH, Lee JM, Ryu KS, et al. Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer. J Surg Oncol 2010; 101: 149\u2013155.","DOI":"10.1002\/jso.21448"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Abu-Elhasan AM, Abdellah MS, Hamed HO. Safety and efficacy of postoperative continuous intra-peritoneal wash with lactated Ringer\u2019s for minimizing post-myomectomy pelvic adhesions: a pilot clinical trial. Eur J Obstet Gynecol Reprod Biol 2014; 183: 78\u201382.","DOI":"10.1016\/j.ejogrb.2014.09.002"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/67\/3\/67_19-104\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T03:51:46Z","timestamp":1604721106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/67\/3\/67_19-104\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.19-104","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}